Revisado por Isabelle Baião de Mello Neto (CRF-MG 24309)Informações legais do Cellexina
MS nº 1.3764.0026
Farm. Resp.:
Juliana Aguirre M. Pinto
CRF-ES nº 3198
Fabricado por:
Nortis Farmacêutica Ltda.
Rua João Guilherme, 500 - Londrina/PR
Registrado por:
Aspen Pharma Indústria Farmacêutica Ltda.
Avenida Acesso Rodoviário, Módulo 01, Quadra 09, TIMS – Serra/ES
CNPJ: 02.433.631/0001-20
Indústria Brasileira.
Venda sob prescrição médica.
Só pode ser vendido com retenção da receita.
Referências Bibliográficas
1. Drug Information for the Health Care Professional – USP DI, 27th Edition, 2007, Thomson – Micromedex.
2. Drug Information, 2010, American Society of Health-System Pharmacists.
3. Lyons RW, Andriole VT. Cephalexin: clinical and laboratory studies. Yale J Biol Med. 1971 Oct; 44(2):187-198.
4. Davies JA, Strangeways JEM, Mitchell RG, Beilin LJ, Ledingham JGG, Holt JM. Comparative double-blind trial of cephalexin and ampicillin in treatment of urinary infections. BR Med J. 1971 Jul 24; 3(5768): 215-217.
5. Rabinovitch M, MacKenzie R, Brazeau M, Marks MI. Treatment of streptococcal pharyngitis. I. Clinical evaluation. Can Med Assoc J. 1973 May 19; 108(10): 1271- 1274.
6. Matsen JM, Torstenson O, Siegel SS, Bacaner H. Use of available dosage forms of cephalexin in clinical comparison with phenoxymethil penicillin and benzathine penicillin in the treatment of streptococcal pharyngitis in children. Antimicrob Agents Chemother. 1974 Oct; 6(4): 501-506.
7. Reisberg BE, Mandelbaum JM. Cephalexin: absorption and excretion as related to renal function and hemodialysis. Infect Immun. 1971 Apr; 3(4): 540-543.